VisualDx this week announced that the American Medical Women’s Academy, which is dedicated to advancing women in medicine and improving women’s health, will be able to use its platform for AI-enabled clinical research and…
Continue Reading
Andrew Barnhill, Head of Public Policy, Global Legal, IQVIAAlexandra Weiss, Director of Strategic Partnerships, Patient Advocacy Organizations, IQVIADiversity is paramount to the success of clinical research, both ethically and scientifically. Without adequate representation of…
Continue Reading
The Office of the National Coordinator for Health Information Technology has developed a toolkit that gathers community engagement, health IT standards, infrastructure, interoperability and governance information to help support communities working to achieve health equity.WHY IT…
Continue Reading
The underdiagnosed and poor management of COPD exacerbations represents a missed opportunity to prevent patient deterioration through proactive treatment approaches.
Chronic obstructive pulmonary disorder (COPD) remains a leading cause of poor health and mortality the…
Baptist Memorial will deploy LockDeep’s advanced telehealth technology throughout its system of 22 affiliate hospitals.WHY IT MATTERS
The collaboration utilizes LookDeep’s Clinical Action Platform, built on modern SOC2 Type II audited software, to provide Baptist…
With a dedicated focus on hearing care, the funding will strengthen Tuned’s ability to bridge the gap between audiologists and the general public as a key employee benefit
Tuned, a digital hearing health company focused…
Acquisition further advances CVS Health’s care delivery strategy for consumers
CVS Health® (NYSE: CVS) and Oak Street Health (NYSE: OSH) have entered into a definitive agreement under which CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.
Oak Street Health is…
Geographic atrophy, an eye disorder that starts as a loss of central vision and progressively worsens to total blindness, now has its first treatment. The FDA on Friday approved an Apellis Pharmaceuticals drug that slows the progression of this disease, which affects more than 1 million people in the U.S.
Approval of the Apellis drug, pegcetacoplan, covers all patients with geographic atrophy, a broad label that reflects the representative patient population tested in pivotal studies, Chief Medical Officer Caroline Baumal said during a Friday evening conference call. The Waltham, Massachusetts-based company plans to launch the drug in March, marketing the product under…
The challenges of designing effective clinical trials, finding the right people to participate in them and building trial cohorts that are representative of the population at large, have been well-documented.With its recent Life Sciences initiative, Epic has set its sights on data-driven insights to improve the development of new therapeutics and interventions. That includes improving all parts of the clinical trial process – from how physicians educate their patients about potential cohorts, matching and connecting patients with promising research and helping make sure those studies are optimally beneficial for as many people as possible. Epic is already helping its provider customers…
Continue Reading
Pete speaks with a lot of people who have a clinical background. They have done the hard work to be a doctor, a nurse, or an allied health provider. They go through the training, they get all the…
Continue Reading
